Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Viola Brands is a leading premium cannabis company founded in 2011 by former NBA player Al Harrington. The company is named after Harrington's grandmother, whose successful treatment of glaucoma with cannabis inspired the brand's mission. As a multi-state operator, Viola specializes in the cultivation, processing, and distribution of high-quality cannabis products, including flower, live resin, and concentrates. The company is widely recognized for its commitment to social equity, focusing on increasing minority representation and reinvesting in communities disproportionately affected by the War on Drugs. While serving the recreational market, Viola's products are also utilized for medical purposes, targeting indications such as chronic pain and inflammation. The brand has expanded its footprint across several U.S. states and has established high-profile partnerships to broaden its market reach.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Viola Brands.